glp-1 for bulimia Beyond weight loss: Integrating RA therapies into psychological and behavioral care obesity and binge eating disorder | Reviews in Endocrine and Metabolic Disorders GLP-1 and Eating Disorders: Risks

Popovich IG, Voitenkov BO, Anisimov VN, Ivanov VT, Mikhaleva II, Zabezhinski MA, Alimova IN, Baturin DA, Zavarzina NY, Rosenfeld SV, Semenchenko AV, Yashin AI

Cognitive and Mood Support: Some studies suggest Ipamorelin has neuroprotective effects, helping with focus, memory, and mood balance

Valid for 12 months since the production date

Synthetic small molecule SIRT1 activators Compared with natural products, synthetic SIRT1 activators offer several advantages, including defined molecular structures, high target selectivity, and stable pharmacokinetic profiles, making them a promising direction for the clinical application of SIRT1-targeted therapies